Product image of Minims (Phenylephrine Hydrochloride) supplied by GNH India

Minims

Active Ingredient:
Phenylephrine Hydrochloride
Origin:
EU

Minims (Phenylephrine Hydrochloride)

Phenylephrine Hydrochloride, the active ingredient in Minims, is an alpha‑adrenergic agonist presented as a topical ophthalmic solution for ocular use. It is indicated for use in adult patients undergoing ophthalmic procedures where controlled mydriasis and reduction of ocular hyperemia are required.

GNH India supplies Minims as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to European Union pharmacopeial standards and is manufactured under GMP conditions. Minims is marketed throughout the European Union and exported to other regions.

Manufacturer / TM Owner

Bausch + Lomb Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Phenylephrine Hydrochloride is an alpha‑adrenergic agonist used in ophthalmology to manage pupil size and ocular redness.

  • Ophthalmic examination: induces mydriasis to allow thorough retinal and anterior segment evaluation.
  • Intraocular surgery: provides controlled pupil dilation to facilitate surgical access.
  • Ocular hyperemia: reduces conjunctival redness for improved visual comfort.

How It Works

  • Phenylephrine Hydrochloride acts as a selective alpha‑1 adrenergic receptor agonist on the radial iris dilator muscle. Activation of these receptors triggers contraction of the dilator muscle, leading to pupil enlargement (mydriasis). In the conjunctival vessels, alpha‑1 stimulation causes vasoconstriction, decreasing blood flow and thereby reducing hyperemia. The combined actions produce a clear ocular field for examination or surgery.

Side Effects

Phenylephrine Hydrochloride may cause ocular and systemic adverse reactions, most of which are mild and transient.

Common Side Effects

  • Burning or stinging sensation: mild discomfort upon instillation.
  • Transient blurred vision: temporary reduction in visual acuity.
  • Mild conjunctival redness: slight irritation after use.
  • Headache: occasional mild headache.

Serious or Rare Side Effects

  • Increased intraocular pressure: may exacerbate glaucoma.
  • Systemic hypertension: elevated blood pressure in susceptible individuals.
  • Cardiac arrhythmia: irregular heart rhythm in patients with cardiovascular disease.
  • Allergic reaction: rash, swelling, or itching around the eye.

Precautions & Warnings

When using Phenylephrine Hydrochloride, certain precautions should be observed to minimize risk.

  • Contraindication in glaucoma: avoid use in patients with narrow‑angle or uncontrolled glaucoma.
  • Cardiovascular disease: use cautiously in individuals with hypertension or heart disease.
  • Pregnancy and lactation: safety not established; prescribe only if benefit outweighs risk.
  • Pediatric use: not recommended for children without specialist guidance.
  • Drug interactions: review concomitant alpha‑agonists or MAO inhibitors.
  • Store at room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Phenylephrine Hydrochloride can interact with several systemic agents; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): may cause severe hypertension.
  • Tricyclic antidepressants: additive pressor effects.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may blunt cardiovascular response.
  • Other sympathomimetics: increase risk of tachycardia.
  • Antihypertensive agents: may reduce efficacy of blood pressure control.

Frequently Asked Questions

Minims contains phenylephrine hydrochloride and is used to produce pupil dilation (mydriasis) and to lessen conjunctival redness during eye examinations or surgical procedures. It helps clinicians obtain a clear view of intra‑ocular structures and improves patient comfort by reducing ocular hyperemia.

Phenylephrine hydrochloride selectively stimulates alpha‑1 adrenergic receptors on the iris dilator muscle, causing the muscle to contract and the pupil to enlarge. It also activates alpha‑1 receptors on conjunctival blood vessels, leading to vasoconstriction and a reduction in redness.

The specific dose and frequency of Minims are determined by the prescribing eye‑care professional based on the patient’s condition, the required degree of mydriasis, and the clinical setting. No fixed regimen is provided here; the prescriber sets the appropriate regimen.

Safety data for phenylephrine hydrochloride in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by the treating physician.

To order Minims, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with agents such as tropicamide, phenylephrine provides a faster onset of pupil dilation and a stronger vasoconstrictive effect, which can be advantageous when rapid mydriasis and reduction of redness are needed. However, phenylephrine may have a higher risk of systemic cardiovascular effects, so patient selection is important.

Minims should be stored at room temperature, below 25 °C, in its original packaging. Protect the container from direct sunlight and moisture. Do not freeze the product, and keep it out of reach of children.

Minims is applied topically to the eye as a drop. The prescribed number of drops is placed in the conjunctival sac of the target eye(s) using a sterile technique. The patient should avoid touching the tip of the bottle to the eye or surrounding tissues.

Serious risks include a rise in intra‑ocular pressure that could worsen glaucoma, systemic hypertension, and rare allergic reactions such as swelling or rash around the eye. Patients with known cardiovascular disease or narrow‑angle glaucoma should be monitored closely.

Minims should not be used in individuals with narrow‑angle or uncontrolled glaucoma, severe hypertension, known hypersensitivity to phenylephrine, or in children unless specifically directed by an ophthalmologist. Caution is also advised for patients taking MAO inhibitors or other sympathomimetic drugs.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Phenylephrine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT